Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common stock, Par Value $0.0001 Per Share
-
Shares outstanding
-
13M
-
Number of holders
-
12
-
Total shares
-
281K
-
Shares change
-
-5.6K
-
Total reported value, excl. options
-
$283K
-
Value change
-
-$30K
-
Number of buys
-
5
-
Number of sells
-
-5
-
Price
-
$1.01
Significant Holders of Jaguar Health, Inc. - Common stock, Par Value $0.0001 Per Share (JAGX) as of Q4 2024
16 filings reported holding JAGX - Jaguar Health, Inc. - Common stock, Par Value $0.0001 Per Share as of Q4 2024.
Jaguar Health, Inc. - Common stock, Par Value $0.0001 Per Share (JAGX) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 281K shares
of 13M outstanding shares and own 2.15% of the company stock.
Largest 10 shareholders include GEODE CAPITAL MANAGEMENT, LLC (96.7K shares), VANGUARD GROUP INC (59.5K shares), UBS Group AG (50.7K shares), HRT FINANCIAL LP (32.8K shares), STATE STREET CORP (15.1K shares), Virtu Financial LLC (13.8K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (11.5K shares), MORGAN STANLEY (252 shares), BlackRock, Inc. (110 shares), and SBI Securities Co., Ltd. (103 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.